Prescribing Resources
The Liverpool Drug Interaction Group (based at the University of Liverpool, UK), in collaboration with the University Hospital of Basel (Switzerland) and Radboud UMC (Netherlands), have produced various materials in PDF format to aid the use of experimental agents in the treatment of COVID-19.
Please check this site regularly for updates and additional information.
- Overview of interactions with experimental COVID-19 therapies.
- Click here to view PDF. Updated 12 March 2020
- Further details of interactions with experimental COVID-19 therapies.
- Click here to view PDF. Updated 12 March 2020
- Administration in cases of swallowing difficulties.
- Click here to view PDF. Updated 14 March 2020